✦ LIBER ✦

A phase I/II trial with chimeric monoclonal antibody WX-G250 in combination with low dose interleukin-2 for patients with metastatic renal cell carcinoma

✍ Scribed by I. Bleumer; J. Beck; Oosterwijk; C. Mala; S. Ullrich; P.F.A. Mulders

Book ID: 118644542
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 199 KB
Volume: 2
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(03)80389-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Clinical Trial With Chimeric Monoclona

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

✍ Bleumer, I.; Oosterwijk, E.; Oosterwijk-Wakka, J.C.; Völler, M.C.W.; Melchior, S 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 139 KB

A phase II trial with monoclonal antibod

A phase II trial with monoclonal antibody WX-G250 in advanced renal cell carcinoma

✍ I. Bleumer; J. Beck; R. Hofmann; W. Kruit; S. Warnaar; C. Mala; S. Ullrich; C. H 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Re: A Clinical Trial With Chimeric Monoc

Re: A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

✍ Doehn, Christian 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 36 KB

291 Phase I/II multicentre study with th

291 Phase I/II multicentre study with the monoclonal antibody WX-G250 in combination with interferon α-2A in metastatic renal cell carcinoma

✍ M. Siebels; K. Rohrmann; R. Oberneder; A. Hofstetter; Z. Varga; R. Hoffmann; M. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

A clinical phase I/II trial with the mon

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients

✍ M. Siebels; K. Rohrmann; R. Oberneder; M. Stahler; N. Haseke; J. Beck; R. Hofman 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 311 KB

Phase I/II study of thalidomide in combi

Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma

✍ Robert J. Amato; Margaret Morgan; Anish Rawat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views